MSA
BMY icon

Marino Stram & Associates’s Bristol-Myers Squibb BMY Stock Holding History

Marino Stram & Associates’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5,304
Closed -$308K – 169
2023
Q3 		$308K Sell
5,304
-144
-3% -$8.82K 0.09% 123
2023
Q2 		$348K Buy
5,448
+4
+0.1% +$268 0.1% 119
2023
Q1 		$377K Buy
5,444
+27
+0.5% +$1.9K 0.11% 110
2022
Q4 		$390K Sell
5,417
-1,463
-21% -$110K 0.12% 106
2022
Q3 		$489K Buy
6,880
+71
+1% +$5.15K 0.18% 88
2022
Q2 		$524K Sell
6,809
-14
-0.2% -$1.07K 0.18% 89
2022
Q1 		$498K Sell
6,823
-194
-3% -$13K 0.16% 102
2021
Q4 		$437K Sell
7,017
-444
-6% -$26K 0.13% 109
2021
Q3 		$441K Sell
7,461
-13,173
-64% -$868K 0.15% 101
2021
Q2 		$1.38M Buy
20,634
+13,791
+202% +$899K 0.36% 65
2021
Q1 		$432K Sell
6,843
-292
-4% -$18.2K 0.17% 89
2020
Q4 		$443K Buy
7,135
+1,325
+23% +$81.5K 0.2% 76
2020
Q3 		$350K Buy
5,810
+184
+3% +$11.1K 0.19% 78
2020
Q2 		$331K Buy
5,626
+890
+19% +$53.2K 0.2% 77
2020
Q1 		$264K Sell
4,736
-1,889
-29% -$115K 0.2% 73
2019
Q4 		$425K Buy
6,625
+873
+15% +$50K 0.28% 57
2019
Q3 		$292K Sell
5,752
-1,069
-16% -$50.2K 0.21% 66
2019
Q2 		$309K Sell
6,821
-583
-8% -$27.2K 0.23% 64
2019
Q1 		$353K Buy
7,404
+213
+3% +$10.6K 0.25% 55
2018
Q4 		$374K Sell
7,191
-60
-0.8% -$3.22K 0.33% 51
2018
Q3 		$450K Sell
7,251
-43
-0.6% -$2.55K 0.36% 48
2018
Q2 		$404K Sell
7,294
-165
-2% -$8.91K 0.36% 50
2018
Q1 		$472K Buy
7,459
+135
+2% +$8.69K 0.44% 49
2017
Q4 		$449K Buy
+7,324
New +$458K 0.41% 48

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Marino Stram & Associates's BMY Position: Q4 2023 in Review

Marino Stram & Associates sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 5,304 shares — an estimated $308K sold.

Marino Stram & Associates first reported a position in BMY in Q4 2017 and held it in 24 quarters. The position peaked at $1.38M in Q2 2021. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

  • Marino Stram & Associates reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
  • Marino Stram & Associates sold 5,304 Bristol-Myers Squibb shares in Q4 2023, an estimated $308K.
  • Marino Stram & Associates first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 24 quarters.
  • Marino Stram & Associates's Bristol-Myers Squibb position peaked at $1.38M in Q2 2021.
  • 2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Marino Stram & Associates's 13F filing for Q4 2023, filed 30 Jan 2024.